Scott Dorfman BBA

Scott Dorfman is president and CEO of Odylia Therapeutics, a non-profit biotech company whose mission is to facilitate the translation of rare disease with proof-ofconcept from the lab into clinical trials. Prior to Odylia, Mr. Dorfman founded and was Chairman, & CEO of Innotrac Corporation (NASDAQ: INOC), which was a full-service provider of eCommerce technology, fulfillment, and call center services. Founded in 1984, Innotrac employed over 2,500 employees with $250 million in revenues. The company was taken private by Mr. Dorfman along with Sterling Capital and Longview Capital in 2014 and combined with eBay Enterprises (division of eBay) to form Radial Corporation.